[HTML][HTML] First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease

J Lammer, M Bosiers, T Zeller, M Schillinger… - Journal of vascular …, 2011 - Elsevier
BACKGROUND: A novel self-expanding drug-eluting stent was designed to slowly release
everolimus to prevent restenosis following peripheral arterial intervention. The purpose of …

Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness …

MD Dake, D Scheinert, G Tepe… - Journal of …, 2011 - journals.sagepub.com
Purpose To report a prospective, single-arm, multicenter clinical study evaluating the Zilver
PTX drug-eluting stent for treating the above-the-knee femoropopliteal segment …

Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts

EE Joviliano, CE Piccinato… - Annals of vascular …, 2011 - Elsevier
In this article, we review the current status of inflammation linked to percutaneous
transluminal angioplasty with stent implantation, especially as it relates to restenosis and its …

Local drug delivery for treatment of coronary and peripheral artery disease

ZM Gertz, RL Wilensky - Cardiovascular therapeutics, 2011 - Wiley Online Library
Local drug delivery (LDD), the direct application of a therapeutic agent to a focal location,
has been used in cardiovascular interventions to prophylactically reduce neointimal …

Comparison of diamond-like carbon-coated nitinol stents with or without polyethylene glycol grafting and uncoated nitinol stents in a canine iliac artery model

JH Kim, JH Shin, DH Shin, MW Moon… - The British Journal of …, 2011 - academic.oup.com
Objective: Neointimal hyperplasia is a major complication of endovascular stent placement
with consequent in-stent restenosis or occlusion. Improvements in the biocompatibility of …

The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients

IS Chang, HK Chee, SW Park, IJ Yun… - Korean Journal of …, 2011 - synapse.koreamed.org
Objective We wanted to evaluate the status of self-expandable nitinol stents implanted in the
P2 and P3 segments of the popliteal artery in Korean patients. Materials and Methods We …

Claudication: treatment options for femoropopliteal disease

M Schillinger, E Minar - Progress in cardiovascular diseases, 2011 - Elsevier
Intermittent claudication due to chronic femoropopliteal obstruction is a common disease,
and patients are potentially severely disabled by the painful limitation of walking capacity …

Drug‐eluting stents and balloons in peripheral arterial disease: evidence so far

YC Chan, SW Cheng - International journal of clinical practice, 2011 - Wiley Online Library
Restenosis by myointimal hyperplasia after peripheral arterial angioplasty or stenting is a
major problem limiting its long‐term efficiency and patency, and may lead to recurrent …

Popliteal pseudoaneurysm caused by stent fracture

Y Tsuji, I Kitano, O Iida, S Kajita, K Sawada… - Annals of vascular …, 2011 - Elsevier
Stent fracture with pseudoaneurysm formation in the femoropopliteal artery has uncommonly
been reported. We present the case of a 72-year-old man with a fracture of self-expanding …

Современные принципы лечения хронической критической ишемии нижних конечностей

ЛА Бокерия, РА Абдулгасанов… - Клиническая физиология …, 2011 - elibrary.ru
Герасимов, ВБ Фармакоэкономика вазапростана при критической ишемии нижних
конечностей/ВБ Герасимов, МВ Авксентьева, ПА Воробьев//Ангиол. и сосуд. хир.-2001 …